1.Specification
Product name: |
Sildenafil citrate |
Other Name |
Sildenafil citrate; viagra; |
Original |
China |
CAS |
171599-83-0 |
Molecular formula |
C28H38N6O11S |
Brand name |
NJBNSteroid |
Drug Class |
Oral Steroid |
Delivery time |
within 24 hours upon receipt of payment |
Delivery |
Fast and secure shipping by EMS, DHL, TNT, FedEx, UPS |
Purity |
98% |
Melting point |
187-189°C |
Package |
Discreet and Hidden package according to specific requirement |
Appearance |
White Crystalline Powder |
Certification |
SGS, ISO 9001 |
Payment Terms |
Western unio, Money Gram , T/T, Bitcoin |
Minimum Order Quantity |
10 g |
Price |
Negotiable |
Usage |
An orally active Sildenafil, sold as Viagra and other trade names, is a medication used to treat erectile dysfunction and pulmonary arterial hypertension. |
Dosage
For most men, the recommended dose is 50 mg. Based on effectiveness and toleration, the dose may be increased to a maximum recommended dose of 100 mg or decreased to 25 mg. The maximum recommended dosing frequency is once per day. Be sure to tell your doctor about all of the medications you take and any other medical conditions as your dose may need to be adjusted.
Description and Application:
Sildenafil citrate, sold as Viagra, Revatio and under various other trade names, is a drug used to treat erectile dysfunction and pulmonary arterial hypertension (PAH). It was originally discovered by Pfizer scientists Andrew Bell, David Brown, and Nicholas Terrett.
The primary indication of sildenafil is treatment of erectile dysfunction (inability to sustain a satisfactory erection to complete intercourse). Its use is now standard treatment for erectile dysfunction in all settings, including diabetes.
In clinical trials, the most common adverse effects of sildenafil use included headache, flushing, dyspepsia, nasal congestion and impaired vision, including photophobia and blurred vision.Some sildenafil users have complained of seeing everything tinted blue (cyanopsia).Some complained of blurriness and loss of peripheral vision. In July 2005, the FDA found that sildenafil could lead to vision impairment in rare cases and a number of studies have linked sildenafil use with nonarteritic anterior ischemic optic neuropathy.